Literature DB >> 28671725

Trisomy 13-confined placental mosaicism: is there an increased risk of gestational hypertensive disorders?

Sarah K Dotters-Katz1, Emily Hardisty1, Erin Campbell1, Neeta Vora1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28671725      PMCID： PMC5944320          DOI： 10.1002/pd.5105

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN： 0197-3851            Impact factor:   3.050


× No keyword cloud information.
  10 in total

1.  The type of feto-placental aneuploidy detected by cfDNA testing may influence the choice of confirmatory diagnostic procedure.

Authors:  Francesca Romana Grati; Komal Bajaj; Francesca Malvestiti; Cristina Agrati; Beatrice Grimi; Barbara Malvestiti; Eva Pompilii; Federico Maggi; Susan Gross; Giuseppe Simoni; Jose Carlos P Ferreira
Journal:  Prenat Diagn       Date:  2015-09-11       Impact factor: 3.050

2.  Placental expression of angiogenic factors in Trisomy 13.

Authors:  Michelle Silasi; Sarosh Rana; Camille Powe; Bruce Cohen; Kee-Hak Lim; Zsuzsanna K Zsengellér; S Ananth Karumanchi; Isaac E Stillman
Journal:  Am J Obstet Gynecol       Date:  2011-04-20       Impact factor: 8.661

3.  The classification, diagnosis and management of the hypertensive disorders of pregnancy: A revised statement from the ISSHP.

Authors:  A L Tranquilli; G Dekker; L Magee; J Roberts; B M Sibai; W Steyn; G G Zeeman; M A Brown
Journal:  Pregnancy Hypertens       Date:  2014-02-15       Impact factor: 2.899

4.  Fetal aneuploidy screening by maternal plasma DNA sequencing: 'false positive' due to confined placental mosaicism.

Authors:  H Choi; T K Lau; F M Jiang; M K Chan; H Y Zhang; P S S Lo; F Chen; L Zhang; W Wang
Journal:  Prenat Diagn       Date:  2012-11-27       Impact factor: 3.050

5.  Cytogenetic follow-up of chromosomal mosaicism detected in first-trimester prenatal diagnosis.

Authors:  Paola Battaglia; Anna Baroncini; Angela Mattarozzi; Ilaria Baccolini; Antonella Capucci; Francesca Spada; Eva Pompilii; Maria Carla Pittalis
Journal:  Prenat Diagn       Date:  2014-04-08       Impact factor: 3.050

6.  Pre-eclampsia and trisomy 13: a possible association.

Authors:  P A Boyd; R H Lindenbaum; C Redman
Journal:  Lancet       Date:  1987-08-22       Impact factor: 79.321

7.  Pre-eclampsia and trisomy 13.

Authors:  C Bower; F Stanley; B N Walters
Journal:  Lancet       Date:  1987-10-31       Impact factor: 79.321

8.  Birth history, physical characteristics, and medical conditions in long-term survivors with full trisomy 13.

Authors:  Deborah Bruns
Journal:  Am J Med Genet A       Date:  2011-10-11       Impact factor: 2.802

9.  Positive cell-free fetal DNA testing for trisomy 13 reveals confined placental mosaicism.

Authors:  April L Hall; Holli M Drendel; Jennifer L Verbrugge; Angela M Reese; Katherine L Schumacher; Christopher B Griffith; David D Weaver; Mary P Abernathy; Christian G Litton; Gail H Vance
Journal:  Genet Med       Date:  2013-03-14       Impact factor: 8.822

10.  Cell-free DNA testing in a trisomy 21 pregnancy with confined placental mosaicism for a cell line with trisomy for both chromosomes 18 and 21.

Authors:  Kristy Crooks; Ginger Edwardsen; Siobhan O'Connor; Cynthia Powell; Diane Vargo; Neeta Vora; Kathleen Kaiser-Rogers
Journal:  Clin Case Rep       Date:  2015-11-09
  10 in total
  1 in total

Review 1.  The etiology of preeclampsia.

Authors:  Eunjung Jung; Roberto Romero; Lami Yeo; Nardhy Gomez-Lopez; Piya Chaemsaithong; Adithep Jaovisidha; Francesca Gotsch; Offer Erez
Journal:  Am J Obstet Gynecol       Date:  2022-02       Impact factor: 8.661
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.